Page last updated: 2024-08-23

mifepristone and Blood Loss, Surgical

mifepristone has been researched along with Blood Loss, Surgical in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, H; Du, L; Li, S; Li, YY; Xu, H; Yin, ZY; Zhang, B; Zhang, XP; Zhou, XY	1
Fichez, A; Huissoud, C; Lamblin, G; Le Gall, J; Philip, CA	1
Coyaji, K; Ellertson, C; Harper, C; Winikoff, B	1

Trials

1 trial(s) available for mifepristone and Blood Loss, Surgical

Article	Year
Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1998, Volume: 63, Issue:1 Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Blood Loss, Surgical; Cuba; Feasibility Studies; Female; Humans; India; Logistic Models; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Uterine Hemorrhage	1998

Article

Year

Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1998, Volume: 63, Issue:1

Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Blood Loss, Surgical; Cuba; Feasibility Studies; Female; Humans; India; Logistic Models; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Uterine Hemorrhage

1998

Other Studies

2 other study(ies) available for mifepristone and Blood Loss, Surgical

Article	Year
Comparison of transvaginal surgery and methotrexate/mifepristone-combined transcervical resection in the treatment of cesarean scar pregnancy. European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:12 Topics: Adult; Blood Loss, Surgical; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Length of Stay; Methotrexate; Mifepristone; Operative Time; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome; Uterine Artery Embolization	2017
[Cesarean scar ectopic pregnancies: combined modality therapies with uterine artery embolization before surgical procedure]. Gynecologie, obstetrique & fertilite, 2015, Volume: 43, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Blood Loss, Surgical; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Gestational Age; Humans; Hysterectomy; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Uterine Artery Embolization	2015

Article

Year

Comparison of transvaginal surgery and methotrexate/mifepristone-combined transcervical resection in the treatment of cesarean scar pregnancy.

European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:12

Topics: Adult; Blood Loss, Surgical; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Length of Stay; Methotrexate; Mifepristone; Operative Time; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome; Uterine Artery Embolization

2017

[Cesarean scar ectopic pregnancies: combined modality therapies with uterine artery embolization before surgical procedure].

Gynecologie, obstetrique & fertilite, 2015, Volume: 43, Issue:3

Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Blood Loss, Surgical; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Gestational Age; Humans; Hysterectomy; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Uterine Artery Embolization

2015